Search for "organometallic complexes" in Full Text gives 31 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2014, 10, 1166–1196, doi:10.3762/bjoc.10.117
Graphical Abstract
Scheme 1: Pioneer works of Atherton, Openshaw and Todd reporting on the synthesis of phosphoramidate starting...
Scheme 2: Mechanisms 1 (i) and 2 (ii) suggested by Atherton and Todd in 1945; adapted from [1].
Scheme 3: Two reaction pathways (i and ii) to produce chlorophosphate 2. Charge-transfer complex observed whe...
Scheme 4: Mechanism of the Atherton–Todd reaction with dimethylphosphite according to Roundhill et al. (adapt...
Scheme 5: Synthesis of dialkyl phosphate from dialkyl phosphite (i) and identification of chloro- and bromoph...
Scheme 6: Synthesis of chiral phosphoramidate with trichloromethylphosphonate as the suggested intermediate (...
Scheme 7: Selection of results that address the question of the stereochemistry of the AT reaction (adapted f...
Scheme 8: Synthesis of phenoxy spirophosphorane by the AT reaction (adapted from [34]).
Scheme 9: Suggested mechanism of the Atherton–Todd reaction, (i) and (ii) formation of chlorophosphate with a...
Scheme 10: AT reaction in biphasic conditions (adapted from [38]).
Scheme 11: AT reaction with iodoform as halide source (adapted from [37]).
Scheme 12: AT reaction with phenol at low temperature in the presence of DMAP (adapted from [40]).
Scheme 13: Synthesis of a triphosphate by the AT reaction starting with the preparation of chlorophosphate (ad...
Scheme 14: AT reaction with sulfonamide (adapted from [42]).
Scheme 15: Synthesis of a styrylphosphoramidate starting from the corresponding aniline (adapted from [43]).
Scheme 16: Use of hydrazine as nucleophile in AT reactions (adapted from [48]).
Scheme 17: AT reaction with phenol as a nucleophilic species; synthesis of dioleyl phosphate-substituted couma...
Scheme 18: Synthesis of β-alkynyl-enolphosphate from allenylketone with AT reaction (adapted from [58]).
Scheme 19: Synthesis of pseudohalide phosphate by using AT reaction (adapted from [67]).
Scheme 20: AT reaction with hydrospirophosphorane with insertion of CO2 in the product (adapted from [69]).
Scheme 21: AT reaction with diaryl phosphite (adapted from [70]).
Scheme 22: AT reaction with O-alkyl phosphonite (adapted from [71]).
Scheme 23: Use of phosphinous acid in AT reactions (adapted from [72]).
Scheme 24: AT reaction with secondary phosphinethiooxide (adapted from [76]).
Scheme 25: Use of H-phosphonothioate in the AT reaction (adapted from [78]).
Scheme 26: AT-like reaction with CuI as catalyst and without halide source (adapted from [80]).
Scheme 27: Reduction of phenols after activation as phosphate derivatives (adapted from [81] i ; [82], ii; and [83], iii).
Scheme 28: Synthesis of medium and large-sized nitrogen-containing heterocycles (adapted from [85]).
Scheme 29: Synthesis of arylstannane from aryl phosphate prepared by an AT reaction (adapted from [86]).
Scheme 30: Synthesis and use of aryl dialkyl phosphate for the synthesis of biaryl derivatives (adapted from [89])....
Scheme 31: Synthesis of aryl dialkyl phosphate by an AT reaction from phenol and subsequent rearrangement yiel...
Scheme 32: Selected chiral phosphoramidates used as organocatalyst; i) chiral phosphoramidate used in the pion...
Scheme 33: Determination of ee of H-phosphinate by the application of the AT reaction with a chiral amine (ada...
Scheme 34: Chemical structure of selected flame retardants synthesized by AT reactions; (BDE: polybrominated d...
Scheme 35: Transformation of DOPO (i) and synthesis of polyphosphonate (ii) by the AT reaction (adapted from [117] ...
Scheme 36: Synthesis of lipophosphite (bisoleyl phosphite) and cationic lipophosphoramidate with an AT reactio...
Scheme 37: Use of AT reactions to produce cationic lipids characterized by a trimethylphosphonium, trimethylar...
Scheme 38: Cationic lipid synthesized by the AT reaction illustrating the variation of the structure of the li...
Scheme 39: Helper lipids for nucleic acid delivery synthesized with the AT reaction (adapted from [130]).
Scheme 40: AT reaction used to produce red/ox-sensitive cationic lipids (adapted from [135]).
Scheme 41: Alkyne and azide-functionalized phosphoramidate synthesized by AT reactions,(i); illustration of so...
Scheme 42: Cationic lipids exhibiting bactericidal action – arrows indicate the bond formed by the AT reaction...
Scheme 43: β-Cyclodextrin-based lipophosphoramidates (adapted from [138]).
Scheme 44: Polyphosphate functionalized by an AT reaction (adapted from [139]).
Scheme 45: Synthesis of zwitterionic phosphocholine-bound chitosan (adapted from [142]).
Scheme 46: Synthesis of AZT-based prodrug via an AT reaction (adapted from [143]).
Beilstein J. Org. Chem. 2014, 10, 863–876, doi:10.3762/bjoc.10.83
Graphical Abstract
Scheme 1: Examples of photoinitiating systems.
Figure 1: Previously reported PIC (based on metal complexes) [45-52].
Figure 2: Previously reported PIC (metal free organic molecules) [54,55].
Scheme 2: Reaction mechanisms for the three-component system PIC/eA/E-Z.
Scheme 3: Reaction mechanisms for the two-component system PIC/eA.
Scheme 4: Reaction mechanisms for the system PIC/eA/add.
Scheme 5: Reaction mechanisms for the system PIC/eD/B-Y.
Figure 3: Typical oxidation and reduction agents used through the photoredox catalysis approach in polymeriza...
Figure 4: Typical monomers that can be polymerized through a photoredox catalysis approach.
Scheme 6: Reaction mechanisms for the system Ru(bpy)32+/Ph2I+/R3SiH.
Scheme 7: Reaction mechanisms for the Ru(ligand)32+/Ph3S+/R3SiH system.
Scheme 8: Reaction mechanisms for the Ru(ligand)32+/Ph2I+/NVK system upon visible lights.
Scheme 9: Reaction mechanisms for the violanthrone/Ph2I+/TTMSS (R3SiH) system upon red lights.
Scheme 10: Reaction mechanisms for the Tr-AD/R-Br/MDEA system upon visible lights.
Scheme 11: The photoredox catalysis for controlled polymerization reactions.
Scheme 12: Reaction mechanisms for the Ru(ligand)32+/MDEA/R-Br system upon visible lights.
Scheme 13: Reaction mechanisms for the Violanthrone/Ru(ligand)32+/Ph2I+/R3SiH system upon visible lights.
Scheme 14: Reaction mechanisms for the MK/amine/triazine system upon visible lights.
Figure 5: The new proposed PIC (Ir(piq)2(tmd)).
Figure 6: UV–visible light absorption spectra for Ir(piq)2(tmd) (2) and Ir(ppy)3 (1); solvent: acetonitrile.
Figure 7: (A) cyclic voltamogramm for Ir(piq)2(tmd) in acetonitrile; (B) absorption (a) and luminescence (b) ...
Figure 8: Photolysis of a Ir(piq)2(tmd)/Ph2I+ solution ([Ph2I+] = 0.023 M, in acetonitrile) upon a halogen la...
Figure 9: ESR spin-trapping spectra for the irradiation of a Ir(piq)2(tmd)/Ph2I+ solution in the presence of ...
Figure 10: (A) Photopolymerization profile of EPOX; photoinitiating system: Ir(piq)2(tmd)/Ph2I+/NVK (1%/2%/3%)...
Figure 11: (A) Photopolymerization profile of TMPTA; initiating systems: (1) Ir(piq)2(tmd)/MDEA (1%/2%) and (2...
Beilstein J. Org. Chem. 2013, 9, 1352–1382, doi:10.3762/bjoc.9.153
Graphical Abstract
Figure 1: Qualitative orbital diagram for a d8 metal in ML4 square-planar and ML3 T-shaped complexes.
Figure 2: Walsh diagram for the d-block of a d8 ML3 complex upon bending of one L–M–L angle.
Figure 3: Neutral Y-shaped Pt complex Y1 [15]. Angles are given in degrees.
Figure 4: General classification of T-shaped Pt(II) structures according to the fourth coordination site.
Figure 5: Hydride, boryl and borylene true T-shaped Pt(II) complexes.
Figure 6: NHC-based true T-shaped Pt(II) complexes.
Figure 7: Phosphine-based agostic T-shaped Pt(II) complexes. Compounds in brackets correspond with hydrido–al...
Figure 8: Phenylpyridine and NHC-based agostic T-shaped Pt(II) complexes.
Figure 9: Counteranion coordination in T-shaped Pt(II) complexes.
Figure 10: Phosphine-based solvento Pt(II) complexes.
Figure 11: Nitrogen-based solvento Pt(II) complexes.
Figure 12: Pincer-based solvento Pt(II) complexes.
Figure 13: Structure of the QM/MM optimized cisplatin–protein adduct [94].
Figure 14: NMR coupling constants used for the characterization of three-coordinate Pt(II) species.
Figure 15: The chemical formula of the complexes discussed in Table 2.
Scheme 1: Halogen abstraction from 1.
Scheme 2: Halogen abstraction from 2 forming the dicationic complex T3 [22].
Scheme 3: Hydrogenation of complexes A5a and A5b [39].
Scheme 4: Hydrogenation of complexes 3 and A5c [40].
Scheme 5: Intermolecular C–H bond activation from T5a [28].
Scheme 6: Protonation of complexes 4 [35,36].
Scheme 7: Cyclometalation of 5 [43].
Scheme 8: Protonation of 6.
Scheme 9: Reductive elimination of ethane from 7.
Scheme 10: Reductive elimination of methane from six-coordinate Pt(IV) complexes.
Scheme 11: Proposed dissociative mechanism for the fluxional motion of dmphen in [Pt(Me)(dmphen)(PR3)]+ comple...
Figure 16: Feasible interactions for unsaturated intermediates 11b (left) and 12b (right) during fluxional mot...
Scheme 12: Halogen abstraction from 13a,b and subsequent cyclometalation to yield complexes A5a,b [39].
Scheme 13: Proposed mechanism for the acid-catalyzed cyclometalation of 14 via intermediate 15 [41].
Scheme 14: Proposed mechanism for the formation of 19 [102].
Scheme 15: Cyclometalation of 20 via thioether dissociation [117].
Figure 17: Gibbs energy profile (in chloroform solvent) for the cyclometalation of 23 [120].
Scheme 16: Coordination of tmtu to 29 and subsequent C–H bond activation via three-coordinate species 31 and 32...
Scheme 17: Cyclometalation process of NHC-based Pt(II) complexes [28,44].
Scheme 18: Cyclometalation process of complex A9 [43].
Scheme 19: “Rollover” reaction of 38 and subsequent oligomerization [123].
Scheme 20: Proposed mechanism for the formation of cyclometalated species 44 [124].
Scheme 21: Self-assembling process of 45 by “rollover” reaction [126].
Scheme 22: “Rollover” reaction of A9. Energies (solvent) in kcal mol−1 [127].
Scheme 23: Proposed mechanisms for the “rollover” cyclometalation of 52 in gas-phase ion-molecule reactions [128].
Scheme 24: β-H elimination and 1,2-insertion equilibrium involving A1d and the subsequent generation of 57 [35].
Scheme 25: Proposed mechanism for thermolysis of 7b and 7c in benzene-d6 and cyclohexane-d12 solvents [101].
Scheme 26: β-H elimination process of A11a [28].
Scheme 27: Intermolecular C–H bond activation from 62 [95].
Scheme 28: Reductive elimination of methane from 65 followed by CD3CN coordination or C–D bond-activation proc...
Figure 18: DFT-optimized structures describing the κ2 (69, left) and κ3 (69’, right) coordination modes of [Pt...
Scheme 29: Intermolecular arene C–H bond activation from NHC-based complexes [28].
Figure 19: Energy profiles (in benzene solvent) for the benzene C–H bond activation from A11a, A11b, T5a and T...
Scheme 30: Intermolecular arene C–H bond activation from PNP-based complex 71 [12].
Scheme 31: Intermolecular C–H bond-activation by gas-phase ion-molecule reactions of 74 [7,142].
Scheme 32: Dihydrogen activation through complexes A5a, A5b [39], A5c [40] and S1a [54].
Scheme 33: Dihydrogen activation through complexes A7 and 16 [41]. For a: see Scheme 13.
Scheme 34: Br2 and I2 bond activations through complexes A11a and T5a [143].
Scheme 35: Detection and isolation of the Pt(III) complex 81a [143].
Scheme 36: Cl2 bond activation through complexes 82 and 83 [144].
Scheme 37: cis–trans Isomerization mechanism of the solvento Pt(II) complexes S5 [2,61].
Figure 20: Energy profiles for the isomerization of complexes [Pt(R)(PMe3)2(NCMe)]+ where R means Me (85a, red...
Figure 21: DFT-optimized structure of intermediate 86 [62]. Bond distances in angstrom and angles in degrees.
Scheme 38: Proposed dissociative ligand-substitution mechanism of cis-[Pt(R)2S2] complexes (87) [117].
Scheme 39: Proposed mechanisms for the ligand substitution of the dinuclear species 91 [146].
Beilstein J. Org. Chem. 2012, 8, 1788–1797, doi:10.3762/bjoc.8.204
Graphical Abstract
Figure 1: Flow cytometric uptake studies of carboxyfluorescein-labeled (sC18)2 in HEK-293 (human embryonic ki...
Figure 2: Top: Fluorescence microscopic images of unfixed HEK-293 cells after 30 min incubation with 1 µM CF-...
Figure 3: Cell viability of different cell lines after 24 h incubation with (sC18)2 at different concentratio...
Figure 4: Cell lysis of HEK-293 cells induced by (sC18)2 after 1 h incubation. Experiments were conducted in ...
Scheme 1: Synthesis of (sC18)2 bioconjugates (a) and chemical structures of the coupled anti-tumor agents (b)...
Figure 5: Chromatogram and ESI-MS of purified Cym2-GFL-(sC18)2. The gradient was 10→60% acetonitrile in water...
Figure 6: Circular dichroism spectra of the (sC18)2 conjugates. Spectra were acquired in 10 mM phosphate buff...
Figure 7: Cell viability of (a) HT-29 and (b) MCF-7 cells after 24 h incubation with the (sC18)2 conjugates a...
Figure 8: Brightfield microscopic images of unfixed HT-29 cells after 24 h incubation with the (sC18)2 conjug...
Figure 9: Cell lysis of (a) HT-29 and (b) MCF-7 cells induced by the (sC18)2 conjugates at different concentr...
Beilstein J. Org. Chem. 2011, 7, 1234–1248, doi:10.3762/bjoc.7.144
Graphical Abstract
Scheme 1: Proposed stepwise mechanism for the zincation of benzene.
Figure 1: Molecular structure of 2 with selective atom labelling. Hydrogen atoms and minor disorder component...
Scheme 2: Synergic metallation of N,N-dimethylaniline (A) with sodium TMP-zincate 1 to produce 2, which was s...
Figure 2: Molecular structure of 3 with selective atom labelling and thermal ellipsoids drawn at the 50% prob...
Scheme 3: Indirect zincation of N,N-dimethylaniline producing 4, 5 and 6, which was then quenched with I2 to ...
Figure 3: Molecular structure of 4 with selective atom labelling and thermal ellipsoids drawn at the 50% prob...
Figure 4: Solvent-separated ion-pair structure of 5 with selective atom labelling and thermal ellipsoids draw...
Figure 5: Molecular structure of 6 with selective atom labelling and thermal ellipsoids drawn at the 50% prob...
Figure 6: Aromatic region of 1H NMR spectra for deuterated benzene solutions of (a) the crude mixture obtaine...
Figure 7: Relative energy sequence of the four theoretical regioisomers of the experimentally observed produc...
Beilstein J. Org. Chem. 2011, 7, 13–21, doi:10.3762/bjoc.7.3
Graphical Abstract
Scheme 1: Alkene metathesis mechanism.
Scheme 2: Metathesis possibilities.
Scheme 3: Metathesis with Re-based alumina supported catalysts.
Figure 1: (E/Z) ratio as a function of conversion. a) MeReO3 supported on alumina and b) MeReO3 supported on ...
Scheme 4: Alkene selectivity of metathesis reactions.
Scheme 5: Hybrid organic–inorganic catalyst containing a Ru–NHC unit.